Beam Therapeutics
Trade Beam Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BEAM
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201.
BEAM Key Statistics
Stock Snapshot
With a market cap of 2.79B, Beam Therapeutics(BEAM) trades at $27.50. The stock has a price-to-earnings ratio of -6.30.
On 2026-02-17, Beam Therapeutics(BEAM) stock moved within a range of $26.20 to $28.50. With shares now at $27.50, the stock is trading +5.0% above its intraday low and -3.5% below the session's peak.
Trading activity shows a volume of 1.24M, compared to an average daily volume of 1.51M.
The stock's 52-week range extends from a low of $13.53 to a high of $36.44.
The stock's 52-week range extends from a low of $13.53 to a high of $36.44.
Analyst ratings
89%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.